Download PDF
Aktuelle Dermatologie 2007; 33(1/02): 17-25
DOI: 10.1055/s-2006-945164
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Diagnostik und Therapie idiopathischer Photodermatosen

Diagnosis and Treatment of Idiopathic PhotodermatosesT.  Gambichler1 , S.  Boms2
  • 1Klinik für Dermatologie und Allergologie der Ruhr-Universität Bochum, St. Josef Hospital (Direktor: Prof. Dr. P. Altmeyer)
  • 2Universitätsklinikum Heidelberg, Hautklinik (Direktor: Prof. Dr. A. Enk)
Further Information

Publication History

Publication Date:
22 February 2007 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Die idiopathischen Photodermatosen (IPD) stellen eine heterogene Gruppe von Erkrankungsbildern dar, die durch pathologische Hautreaktionen in Erscheinung treten, welche durch optische Strahlung insbesondere im Ultraviolett-A-Wellenlängenbereich ausgelöst werden. Die Ätiopathogenese der IPD ist unklar. Die polymorphe Lichtdermatose, die Hidroa vacciniformia, die solare Urtikaria, die aktinische Prurigo und die chronische aktinische Dermatitis sind die wichtigsten Erkrankungen, die zu den IPD gehören. Aufgrund der oft störenden Symptomatik führen die IPD häufig zu einer deutlichen Beeinträchtigung der Lebensqualität der betroffenen Personen. Zur exakten Bestimmung der Aktionsspektren sowie Klärung des Ausmaßes der Photosensitivität sind photodiagnostische Testverfahren unentbehrlich. Die Photoprovokationsprotokolle, Light-Hardening-Verfahren und medikamentösen Behandlungsformen der IPD sind jedoch kaum standardisiert. In diesem Übersichtsartikel werden die klinischen Charakteristika, diagnostischen Maßnahmen und Therapieoptionen der oben genannten IPD kurz diskutiert.

Abstract

The idiopathic photodermatoses (IPD) represent a heterogenous group of conditions appearing with pathological skin reactions that are triggered by optical radiation, particularly in the ultraviolet A wavelength region. The pathogenesis of IPD is obscure. Polymorphic light eruption, hydroa vacciniformia, solar urticaria, and chronic actinic dermatitis are the most important conditions that belong to the IPD. Due to bothersome symptoms such as intractable itch, the IPD frequently result in a significant reduction in quality of life of affected individuals. Photodiagnostic procedures are mandatory for the exact determination of action spectra and degree of photosensitivity. However, photoprovocation tests, light hardening regimens, and drug therapy of IPD are hardly standardized. In this review, the characteristic clinical features, diagnostic measures, and treatment options of IPD are briefly discussed.

Literatur

  • 1 Ferguson J, Dover J S (eds). Photodermatology. London; Manson Publishing 2006
    Google Scholar
  • 2 Ferguson J. Diagnosis and treatment of the common idiopathic photodermatoses.  Australas J Dermatol. 2003;  44 90-96
    CrossrefPubMedGoogle Scholar
  • 3 Stratigos A J, Antoniou C, Papathanakou E, Daboudi M, Tranaka K, Tsara K, Katsambas A D. Spectrum of idiopathic photodermatoses in a Mediterranean country.  Int J Dermatol. 2003;  42 449-454
    CrossrefPubMedGoogle Scholar
  • 4 Hölzle E. Photodermatosen.  Akt Dermatol. 1996;  22 15-19
    PubMedGoogle Scholar
  • 5 Sassa S. The porphyrias.  Photodermatol Photoimmunol Photomed. 2002;  18 56-67
    CrossrefPubMedGoogle Scholar
  • 6 Meffert B, Meffert H. Optische Strahlung und ihre Wirkungen auf die Haut.  Biomed Technik. 2000;  45 98-104
    PubMedGoogle Scholar
  • 7 Mathes R, Sliney D (eds). Measurements of optical radiation hazards. München; Märkl-Druck 1998
    Google Scholar
  • 8 McKinlay A F, Diffey B L. A reference action spectrum for ultraviolet induced erythema in human skin.  CIE J. 1987;  6 17-22
    PubMedGoogle Scholar
  • 9 Lehmann P. Diagnostic approach to photodermatoses.  J Dtsch Dermatol Ges. 2006;  4 965-975
    PubMedGoogle Scholar
  • 10 Roelandts R. The diagnosis of photosensitivity.  Arch Dermatol. 2000;  136 1152-1157
    CrossrefPubMedGoogle Scholar
  • 11 Wolf R, Oumeish O Y. Photodermatoses.  Clin Dermatol. 1998;  16 41-57
    PubMedGoogle Scholar
  • 12 Van de Pas C B, Hawk J L, Young A R, Walker S L. An optimal method for experimental provocation of polymorphic light eruption.  Arch Dermatol. 2004;  140 286-292
    CrossrefPubMedGoogle Scholar
  • 13 Dummer R, Ivanova K, Scheidegger E P, Burg G. Clinical and therapeutical aspects of polymorphous light eruption.  Dermatology. 2003;  207 93-95
    CrossrefPubMedGoogle Scholar
  • 14 Ling T C, Richards H L, Janssens A S, Anastassopoulou L, Antoniou C, Aubin F, Diepgen T L, Fazakerley R, de Gruijl F R, Jansen C T, Pavel S, Smedley A, Stratigos A J, Webb A R, Gibbs N K, Rhodes L E. Seasonal and latitudinal impact of polymorphic light eruption on quality of life.  J Invest Dermatol. 2006;  126 1648-1651
    CrossrefPubMedGoogle Scholar
  • 15 Boonstra H E, van Weelden H, Toonstra J, van Vloten W A. Polymorphous light eruption: a clinical, photobiologic and follow-up study of 110 patients.  J Am Acad Dermatol. 2000;  42 199-207
    CrossrefPubMedGoogle Scholar
  • 16 Ling T C, Gibbs N K, Rhodes L E. Treatment of polymorphic light eruption.  Photodermatol Photoimmunol Photomed. 2003;  19 217-227
    PubMedGoogle Scholar
  • 17 Kolgen W, van Meurs M, Jongsma M, van Weelden H, Bruijnzeel-Koomen C A, Knol E F, van Vloten W A, Laman J, de Gruijl F R. Differential expression of cytokines in UV-B-exposed skin of patients with polymorphous light eruption: correlation with Langerhans cell migration and immunosuppression.  Arch Dermatol. 2004;  140 295-230
    CrossrefPubMedGoogle Scholar
  • 18 Hjorth N, Sjolin K E, Sylvest B, Thomsen K. Acne aestivalis-Mallorca acne.  Acta Derm Venerol. 1972;  52 61-63
    PubMedGoogle Scholar
  • 19 Verbov J. Actinic folliculitis.  Br J Dermatol. 1985;  113 630-631
    CrossrefPubMedGoogle Scholar
  • 20 Veysey E C, George S. Actinic folliculitis.  Clin Exp Dermatol. 2005;  30 659-661
    CrossrefPubMedGoogle Scholar
  • 21 Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases.  J Am Acad Dermatol. 2000;  42 208-213
    CrossrefPubMedGoogle Scholar
  • 22 Demachi A. et al . Characterization of Epstein-Barr Virus (EBV)-positive NK cells isolated from hydroa vacciniforme-like eruptions.  Microbiol Immunol. 2003;  47 543-552
    PubMedGoogle Scholar
  • 23 Iwatsuki K, Xu Z G, Takata M. et al . The association of latent Epstein-Barr virus infection with hydroa vacciniforme.  Br J Dermatol. 1999;  140 715-721
    CrossrefPubMedGoogle Scholar
  • 24 Iwatsuki K. et al . Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.  Arch Dermatol. 2006;  142 587-595
    CrossrefPubMedGoogle Scholar
  • 25 Schauder S. Solar urticaria.  Hautarzt. 2003;  54 952-958
    CrossrefPubMedGoogle Scholar
  • 26 Sams W M. Solar urticaria: studies of the active serum factor.  J Allerg. 1970;  45 295-301
    PubMedGoogle Scholar
  • 27 Kojma M, Horiko T, Nakamara Y, Aoki T. Solar urticaria: relationship of photoallergen and action spectrum.  Arch Dermatol. 1986;  122 550-555
    CrossrefPubMedGoogle Scholar
  • 28 Leenutapong V, Hölzle E, Plewig G. Solar urticaria: studies on the mechanisms of tolerance.  Br J Dermatol. 1990;  122 601-606
    PubMedGoogle Scholar
  • 29 Fukunaga A, Horikawa T, Yamamoto A, Yamada Y, Nishigori C. The inhibition spectrum of solar urticaria suppresses the wheal-flare response follwing intradermal injection with photo-activated autologous serum but not with compound 48/80. Photodermatol Photoimmunol.  Photomed. 2006;  22 129-132
    PubMedGoogle Scholar
  • 30 Hojyo-Tomoka M T, Vega-Memije M E, Cortes-Franco R, Dominguez-Soto L. Diagnosis and treatment of actinic prurigo.  Dermatol Ther. 2003;  16 40-44
    CrossrefPubMedGoogle Scholar
  • 31 Lippert U, Schauder S, Neumann C. Aktinische Prurigo.  Hautarzt. 2000;  51 597-603
    CrossrefPubMedGoogle Scholar
  • 32 Arrese J E, Dominguez-Soto L, Hojyo-Tomoka M T. et al . Effectors of inflammation in actinic prurigo.  J Am Acad Dermatol. 2001;  44 957-961
    CrossrefPubMedGoogle Scholar
  • 33 Gomez A, Umana A, Trespalacios A A. Immune responses to isolated human skin antigens in actinic prurigo.  Med Sci Monit. 2006;  12 106-113
    PubMedGoogle Scholar
  • 34 Hawk J LM. Chronic actinic dermatitis.  Photodermatol Photoimmunol Photomed. 2004;  20 312-314
    PubMedGoogle Scholar
  • 35 Yap L M, Foley P, Crouch R, Baker C. Chronic actinic dermatitis: a retrospective analysis of 44 cases referred to an Australian photobiology unit.  Australas J Dermatol. 2003;  44 256-262
    CrossrefPubMedGoogle Scholar
  • 36 Menage H duP, Sattar N K, Haskard D O, Hawk J LM, Breathnach S M. A study of the kinetics and pattern of E-selectin, VCAM-1 and ICAM-1 expression in chronic actinic dermatitis.  Br J Dermatol. 1996;  134 262-268
    CrossrefPubMedGoogle Scholar
  • 37 Chu A C, Robinson D, Hawk J L, Meacham R, Spittle M F, Smith N P. Immunologic differentiation of the Sezary syndrome due to cutaneous T-cell lymphoma and chronic actinic dermatitis.  J Invest Dermatol. 1986;  86 134-137
    CrossrefPubMedGoogle Scholar
  • 38 Bakels V, van Oostveen J W, Preesman A H, Meijer C JLM, Willemze R. Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor y gene rearrangement analysis and immunophenotyping.  J Clin Pathol. 1998;  51 154-158
    PubMedGoogle Scholar
  • 39 Bilsland D, Crombie I K, Ferguson J. The photosensitivity dermatitis and actinic reticuloid syndrome: no association with lymphoreticular malignancy.  Br J Dermatol. 1994;  131 209-214
    PubMedGoogle Scholar
  • 40 Neumann N J, Fritsch C, Lehmann P. Photodiagnostische Testverfahren Teil 1.  Hautarzt. 2000;  51 113-125
    CrossrefPubMedGoogle Scholar
  • 41 Fitzpatrick T B. The validity and practicality of sun-ractive skin types I and IV.  Arch Dermatol. 1988;  124 869-887
    CrossrefPubMedGoogle Scholar
  • 42 Beattie P E, Dawe R S, Ferguson J, Ibbotson S H. Dose-response and time-course characteristics of UV-A1 erythema.  Arch Dermatol. 2005;  141 1549-555
    CrossrefPubMedGoogle Scholar
  • 43 Gambichler T, Moussa G, Tomi N S, Paech V, Altmeyer P, Kreuter A. Reference limits for erythema effective ultraviolet doses.  Photochem Photobiol. 2006;  82 1097-1102
    CrossrefPubMedGoogle Scholar
  • 44 Murphy G M. Investigation of photosensitive disorders.  Photodermatol Photoimmunol Photomed. 2004;  20 305-311
    PubMedGoogle Scholar
  • 45 Das S, Lloyd J J, Walshaw D, Farr P M. Provocation testing in polymorphic light eruption using fluorescent ultraviolet (UV) A and UVB lamps.  Br J Dermatol. 2004;  151 1066-1070
    CrossrefPubMedGoogle Scholar
  • 46 Bruynzeel D P, Ferguson J, Andersen K, Goncalo M, English J, Goosens A, Hölzle E, Ibbotson S H, Lecha M, Lehmann P, Leonard F, Moseley H, Pigatto O, Tanew A. Photopatch testing: a consensus methodology for Europe.  J Eur Acad Dermatol Venereol. 2004;  18 679-682
    CrossrefPubMedGoogle Scholar
  • 47 Gambichler T, Laperre J, Hoffmann K. The European standard for sun-protective clothing: EN 13 758.  J Eur Acad Dermatol Venereol. 2006;  20 125-130
    CrossrefPubMedGoogle Scholar
  • 48 Hampton P J, Farr P M, Diffey B L, Lloyd J J. Implication for photosensitive patients of ultraviolet A exposure in vehicles.  Br J Dermatol. 2004;  151 873-876
    CrossrefPubMedGoogle Scholar
  • 49 Gambichler T, Altmeyer P, Hoffmann K. Role of clothes in sun protection.  Recent Results Cancer Res. 2002;  160 15-25
    PubMedGoogle Scholar
  • 50 Gambichler T, Laperre J, Altmeyer P, Hoffmann K. UVA and UVB transmission of fabrics: critical wavelength based on absorbance and effective dose.  Exog Dermatol. 2002;  1 290-295
    CrossrefPubMedGoogle Scholar
  • 51 Peyron J L, Raison-Peyron N, Meynadier J, Moyal D, Rougier A, Hourseau C. Prevention of solar urticaria using a broadspectrum sunscreen and determination of a solar urticaria protection factor (SUP).  In: Rougier A, Schaefer H (eds). Protection of the skin against ultraviolet radiation. Paris; John-Libbey Eurotext 1998: 201-205
    Google Scholar
  • 52 Van den Keybus C, Laperre J, Roelandts R. Protection from visible light by commonly used textiles is not predicted by ultraviolet protection.  J Am Acad Dermatol. 2006;  54 86-93
    CrossrefPubMedGoogle Scholar
  • 53 Schauder S, Schrader A, Ippen H. Göttinger Liste 1996. Sonnenschutzkosmetik in Deutschland. 4. neubearbeitete und erweiterte Auflage. Berlin; Blackwell 1996
    Google Scholar
  • 54 Tuchinda C, Lim H W, Osterwalder U, Rougier A. Novel emerging sunscreen technologies.  Dermatol Clin. 2006;  24 105-117
    CrossrefPubMedGoogle Scholar
  • 55 Hönigsmann H. Mechanisms of phototherapy and photochemotherapy for photodermatoses.  Dermatol Therapy. 2003;  16 23-27
    PubMedGoogle Scholar
  • 56 Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A. Narrowband UVB phototherapy in skin conditions beyond psoriasis.  J Am Acad Dermatol. 2005;  52 660-670
    CrossrefPubMedGoogle Scholar
  • 57 Beissert S, Ständer H, Schwarz T. UVA rush hardening for the treatment of solar urticaria.  J Am Acad Dermatol. 2000;  42 1030-1032
    PubMedGoogle Scholar
  • 58 Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses.  Br J Dermatol. 1995;  132 956-963
    PubMedGoogle Scholar
  • 59 Janssens A S, Pavel S, Out-Luiting J J, Willemze R, de Gruijl F R. Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption.  Br J Dermatol. 2005;  152 1268-1274
    CrossrefPubMedGoogle Scholar
  • 60 Darras S, Segard M, Mortier L, Bonnevalle A, Thomas P. Treatment of solar urticaria by intravenous immunoglobulins and PUVA therapy.  Ann Dermatol Venerol. 2004;  131 65-69
    PubMedGoogle Scholar
  • 61 Jeanmougin M, Peyron J L, Thomas P, Beani J C, Guez E, Bachot N. Polymorphic light eruption: prophylaxis using a topical combination of antioxidants and UVA protection formulations.  Ann Dermatol Venereol. 2006;  133 425-428
    PubMedGoogle Scholar
  • 62 Patel D C, Bellaney G J, Seed P T, McGregor J M, Hawk J L. Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomised controlled trial.  Br J Dermatol. 2000;  142 112-114
    CrossrefPubMedGoogle Scholar
  • 63 Wu J J, Huang D B, Pang K R, Hsu S, Tyring S K. Thalidomide: dermatological indications, mechanisms of action and side-effects.  Br J Dermatol. 2005;  153 254-273
    CrossrefPubMedGoogle Scholar
  • 64 Uetsu N, Okamoto H, Fujii K, Doi R, Horio T. Treatment of chronic actinic dermatitis with tacrolimus.  J Am Acad Dermatol. 2002;  47 881-884
    CrossrefPubMedGoogle Scholar
  • 65 Edstrom D W, Ros A M. Cyclosporin A therapy for severe solar urticaria.  Photodermatol Photoimmunol Photomed. 1997;  13 61-63
    PubMedGoogle Scholar
  • 66 Mang R, Stege H, Budde M A, Ruzicka T, Krutmann J. Successful treatment of solar urticaria by extracorporeal photochemotherapy (photopheresis) - a case report. Photodermatol Photoimmunol.  Photomed. 2002;  18 196-198
    PubMedGoogle Scholar
  • 67 Collins P, Ahamat R, Green C, Ferguson J. Plasma exchange therapy for solar urticaria.  Br J Dermatol. 1996;  134 1093-1097
    CrossrefPubMedGoogle Scholar
  • 68 Duschet P, Leyen P, Schwarz T, Hocker P, Greiter J, Gschnait F. Solar urticaria: effective treatment by plasmapheresis.  Clin Exp Dermatol. 1987;  12 185-187
    PubMedGoogle Scholar
  • 69 Evans A V, Palmer R A, Hawk J L. Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus.  Photodermatol Photoimmunol Photomed. 2004;  20 59-61
    PubMedGoogle Scholar
  • 70 Calnan C D, Meara R H. Actinic prurigo (Hutchinson’s summer prurigo).  Clin Exp Dermatol. 1977;  2 365-372
    CrossrefPubMedGoogle Scholar
  • 71 Londono F. Thalidomide in the treatment of actinic prurigo.  Int J Dermatol. 1973;  12 326-328
    PubMedGoogle Scholar

Dr. T. Gambichler

Klinik für Dermatologie und Allergologie
Ruhr-Universität Bochum

Gudrunstr. 56

44791 Bochum

Email: t.gambichler@klinikum-bochum.de